SCHEMBL17748288

SCHEMBL17748288

CCC(Br)OCCCCBr

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22445636 0.93
SCHEMBL4772491 0.82
SCHEMBL5596778 0.81 DNM1 (0.48) DNM1
SCHEMBL1805659 0.81 DNM1 (0.48) DNM1
SCHEMBL155615 0.81 DNM1 (0.48) DNM1
SCHEMBL28419293 0.81 DNM1 (0.48) DNM1
SCHEMBL17748290 0.80 DNM1 (0.35) DNM1
SCHEMBL28055068 0.80
SCHEMBL17748287 0.79 DNM1 (0.38) DNM1
SCHEMBL11816325 0.74 DNM1 (0.33) DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3218349-A2 PROCESSES AND INTERMEDIATES FOR PREPARING , -DICARBOXYLIC ACID-TERMINATED DIALKANE ETHERS Gemphire Therapeutics Inc. (US) 2017-09-20 EP disclosed
WO-2016077832-A2 PROCESSES AND INTERMEDIATES FOR PREPARING α,ω-DICARBOXYLIC ACID-TERMINATED DIALKANE ETHERS GEMPHIRE THERAPEUTICS INC. (US) 2016-05-19 WO disclosed